FSPHX
Price
$25.23
Change
-$0.05 (-0.20%)
Updated
May 8 closing price
Net Assets
6.2B
LYFAX
Price
$12.02
Change
-$0.10 (-0.83%)
Updated
May 8 closing price
Net Assets
40.17M
Ad is loading...

FSPHX vs LYFAX

Header iconFSPHX vs LYFAX Comparison
Open Charts FSPHX vs LYFAXBanner chart's image
Fidelity Select Health Care
Price$25.23
Change-$0.05 (-0.20%)
VolumeN/A
Net Assets6.2B
AlphaCentric Life Sciences & Hlthcare A
Price$12.02
Change-$0.10 (-0.83%)
VolumeN/A
Net Assets40.17M
FSPHX vs LYFAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSPHX vs. LYFAX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a Hold and LYFAX is a StrongSell.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.2B vs. LYFAX (40.2M). LYFAX pays higher dividends than FSPHX: LYFAX (2.00) vs FSPHX (0.02). FSPHX was incepted earlier than LYFAX: FSPHX (44 years) vs LYFAX (5 years). LYFAX (1.91) is less costly to investors than FSPHX (0.63). LYFAX is a more actively managed with annual turnover of: 134.00 vs. FSPHX (40.00). FSPHX has a lower initial minimum investment than LYFAX: FSPHX (0) vs LYFAX (2500). LYFAX annual gain was more profitable for investors over the last year : 0.77 vs. FSPHX (-11.31). LYFAX return over 5 years is better than : 17.16 vs. FSPHX (-11.47).
FSPHXLYFAXFSPHX / LYFAX
Total Expense Ratio0.631.6638%
Annual Report Gross Expense Ratio0.631.9133%
Fund Existence44 years5 years-
Gain YTD-7.229-3.272221%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets6.2B40.2M15,428%
Annual Yield % from dividends0.022.001%
Returns for 1 year-11.310.77-1,466%
Returns for 3 years5.1820.1826%
Returns for 5 years-11.4717.16-67%
Returns for 10 years8.19N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMPEX24.910.38
+1.55%
Beck Mack + Oliver Partners
WBENX12.40N/A
N/A
William Blair Emerging Mkts Growth N
IJSIX14.82N/A
N/A
VY® JPMorgan Small Cap Core Equity I
VMACX56.24N/A
N/A
Virtus KAR Mid-Cap Core A
AULYX91.91N/A
N/A
American Century Ultra® Y